Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteomics in primary brain tumors.

Ping-Pin Zheng1, Johan M Kros, Peter A E Sillevis-Smitt

  • 1Department of Pathology, Erasmus Medical Center Rotterdam, The Netherlands.

Frontiers in Bioscience : a Journal and Virtual Library
|November 29, 2002
PubMed
Summary

Proteomics offers new ways to diagnose and treat primary brain tumors by analyzing protein expression. This review explores proteomic technologies and their diagnostic potential for brain cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Temozolomide Versus Radiotherapy as First-Line Therapy for Low-Grade Glioma: Mature Results of a Randomized Phase III Trial (EORTC 22033-26033/NCIC-CTG/TROG/MRC-CTU).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Heterogeneity of MGMT expression in corticotroph adenomas and mechanism of acquired temozolomide resistance.

The Journal of clinical endocrinology and metabolism·2026
Same author

Concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): final and exploratory analyses of a randomised, open-label, phase 3 trial.

The Lancet. Oncology·2025
Same author

Evolutionary trajectories of IDH-mutant astrocytoma identify molecular grading markers related to cell cycling.

Nature cancer·2025
Same author

Proteomic identification of PA2146 as a biofilm marker of <i>Pseudomonas aeruginosa</i> on endoscope channel material.

Biofilm·2025
Same author

Overexpression of CTLA-4 and fibronectin, and lower expression of CD137 (4-1BB) is associated with brain metastasis of primary skin melanomas. An analysis of local immune response by digital spatial profiling.

Frontiers in immunology·2025

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Genomic alterations in tumors can affect protein expression, influencing diagnosis and treatment.
  • Protein identification in neoplastic tissues is crucial for diagnosis, prognosis, and treatment outcomes.
  • Posttranslational protein modifications may correlate with tumor type and stage.

Purpose of the Study:

  • To review the emerging field of proteomics and its diagnostic applications for primary brain tumors.
  • To discuss various protein separation and identification techniques, including recent advancements.

Main Methods:

  • Review of scientific literature on proteomics and brain tumor research.
  • Description of analytical proteomic technologies for protein identification.

Related Experiment Videos

  • Discussion of bioinformatics applications in integrating genomic, transcriptomic, and proteomic data (operomics).

    • Main Results:

    • Proteomics provides a powerful approach to identify biomarkers for brain tumor diagnosis and prognosis.
    • Advancements in analytical proteomic technology enhance the ability to detect and quantify proteins.
    • The integration of multi-omics data through bioinformatics is essential for a comprehensive understanding of brain tumors.

    Conclusions:

    • Proteomics holds significant diagnostic and therapeutic potential for primary brain tumors.
    • Further research and technological development in proteomics are crucial for clinical applications.
    • Bioinformatics integration is key to leveraging proteomic data for improved brain tumor management.